BioSpace News Archive

Gilead Sciences Update on Supply and Distribution of Veklury ® (remdesivir) in the United States -- Supply of Veklury Is Meeting Real-Time Demand in the U.S. -- -- Clinical Benefits of Veklury Consistently Demonstrated Across Three Randomized, Clinical Trials Are Now Available to All Clinically Appropriate Hospitalized COVID-19 Patients in the U.S. -- -- Veklury Distribution Has Transitioned from the U.S. Government to Gilead --

Lucid Scientific, the biotechnology tools company that develops and manufactures RESIPHER, announced the completion of a $3 million Series Seed financing led by Dynamk Capital.

The Required Use of Face Masks Tied to the Ongoing COVID-19 Pandemic Have Provided Challenges for Those With Hearing Loss. Learn Easy Ways You Can Help.

Phase Genomics, Inc., the biotech leader providing proximity-ligation solutions for the genomics community, announced today the receipt of two NIH grants totaling $3.9M.

DetectaChem, the global leader in innovative portable threat detection technologies used daily by U.S. Homeland Security, Department of Defense and first responder agencies around the world, announces their MobileDetect Bio BCC19 COVID-19 tests are being successfully deployed by prestigious colleges and universities in the U.S. to help support a safe return to campus for students and staff.

Beckman Coulter today announced that it has received Emergency Use Authorization (EUA) for its Access Interleukin-6 (IL-6) assay from the U.S. Food & Drug Administration (FDA).

Magellan Healthcare, the behavioral and specialty health subsidiary of Magellan Health, Inc., announced resources and programs to educate and support individuals in recognition of National Depression and Mental Health Awareness and Screening Month throughout October.

CEIA USA, a premier provider of high-performance Security Metal Detectors, today announced the availability of a new anti-COVID security solution, the CEIA TDU (Thermal Detection Unit) upgrade sensing kit.

Synapse Biomedical, Inc®. (www.synapsebiomedical.com) announced today that surgeons at University Hospitals Cleveland Medical Center have improved the prognosis of several cardiac patients after the use of TransAeris DP for the prevention and treatment of Ventilator Induced Diaphragm Dysfunction (VIDD).

Carmel-based PathogenX, a medical device company that develops, manufactures, and distributes proprietary technology designed to dramatically simplify the process of medical waste disposal, has seen a mounting spike in interest in its PX2 technology, thanks in large part to funding from CARES Act grants enabling qualified medical facilities to obtain the systems with government grant support.